Paper68013
Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
Schneider U and 2 others. Int J Cancer, 1977. Cited by 598 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Papers, record 68013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68013
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Herpesvirus 4, Human | Major topic |
| Leukemia, Lymphoid | Major topic |
| Lymphocytes | Major topic |
| Lymphoma | Major topic |
| Adolescent | |
| Antigens, Viral | |
| Binding Sites | |
| Cell Division | |
| Cell Line | |
| Cell Membrane | |
| Cell Transformation, Neoplastic | |
| Child | |
| Complement System Proteins | |
| Concanavalin A | |
| DNA, Viral | |
| Fluorescent Antibody Technique | |
| Humans | |
| Male | |
| Microscopy, Electron | |
| Receptors, Antigen, B-Cell | |
| Staining and Labeling | |
| T-Lymphocytes | |
| beta 2-Microglobulin |
Source PubMed
Cited by273
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 598 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,469,290 | CD25 genetic ablation on lymphoid cell lines to obtain models of stimulation through the Interleukin-2 beta/gamma receptor. | Sci Rep | 2026 | https://conductscience.org/library/papers/42469290 | PubMed |
| 41,490,986 | Advancing Cancer Immunotherapy: Chimeric Antigen Receptor (CAR)-T Cell Engineering through Novel Screening Methods. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/41490986 | PubMed |
| 41,432,083 | LFC-plus: simultaneous multicolour volume cytometry for high-throughput single-cell analysis. | Lab Chip | 2026 | https://conductscience.org/library/papers/41432083 | PubMed |
| 40,883,026 | High-Resolution aCGH Analysis of the Jurkat Cell Line: Copy Number Alterations and Their Association With Cancer Hallmarks. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/40883026 | PubMed |
| 40,844,672 | The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential. | Purinergic Signal | 2025 | https://conductscience.org/library/papers/40844672 | PubMed |
| 40,810,169 | Discovery of Anticancer Indole-Based 4,5-Dihydroisoxazole Derivative with Selectivity toward Leukemia Cells. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40810169 | PubMed |
| 40,284,914 | Analysis of Factors That Regulate HIV-1 Fusion in Reverse. | Viruses | 2025 | https://conductscience.org/library/papers/40284914 | PubMed |
| 40,190,710 | Lymphoblastoid and Jurkat cell lines are useful surrogate in developing a CRISPR-Cas9 method to correct leukocyte adhesion deficiency genomic defect. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40190710 | PubMed |
| 40,156,187 | An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge. | Mol Ther | 2025 | https://conductscience.org/library/papers/40156187 | PubMed |
| 39,926,208 | Development of a general anti-viral therapeutic using cholestosome technology to exploit inhibition of intracellular viral production. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/39926208 | PubMed |
| 39,796,118 | Zinc Deficiency Exacerbates Lead-Induced Interleukin-2 Suppression by Regulating CREM Expression. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39796118 | PubMed |
| 39,770,138 | Novel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells. | Molecules | 2024 | https://conductscience.org/library/papers/39770138 | PubMed |
| 38,600,336 | Identification of neutrophils and eosinophils in upper airway mucosa with immunofluorescence multiplex image cytometry. | Histochem Cell Biol | 2024 | https://conductscience.org/library/papers/38600336 | PubMed |
| 38,403,442 | Engineering CREB-activated promoters for adenosine-induced gene expression. | Biotechnol J | 2024 | https://conductscience.org/library/papers/38403442 | PubMed |
| 38,291,962 | Temperature Dependence of Membrane Permeability Parameters for Five Cell Types Using Nonideal Thermodynamic Assumptions to Mathematically Model Cryopreservation Protocols. | J Phys Chem B | 2024 | https://conductscience.org/library/papers/38291962 | PubMed |
| 38,225,245 | Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis. | Nat Commun | 2024 | https://conductscience.org/library/papers/38225245 | PubMed |
| 38,167,870 | Mammalian cell growth characterisation by a non-invasive plate reader assay. | Nat Commun | 2024 | https://conductscience.org/library/papers/38167870 | PubMed |
| 37,955,379 | Rapid In Vitro Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging. | J Vis Exp | 2023 | https://conductscience.org/library/papers/37955379 | PubMed |
| 37,745,085 | CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37745085 | PubMed |
| 37,628,755 | Purine Nucleotide Alterations in Tumoral Cell Lines Maintained with Physiological Levels of Folic Acid. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628755 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68013
GET https://conductscience.org/api/papers/v1/68013/cited_by?page=2